Leeds Institute for Medical Research at St James's, University of Leeds, Leeds, UK.
Health Data Insight CIC, Cambridge, UK.
Age Ageing. 2024 May 1;53(5). doi: 10.1093/ageing/afae105.
Numerous studies have revealed age-related inequalities in colorectal cancer care. Increasing levels of frailty in an ageing population may be contributing to this, but quantifying frailty in population-based studies is challenging.
To assess the feasibility, validity and reliability of the Hospital Frailty Risk Score (HFRS), the Secondary Care Administrative Records Frailty (SCARF) index and the frailty syndromes (FS) measures in a national colorectal cancer cohort.
Retrospective population-based study using 136,008 patients with colorectal cancer treated within the English National Health Service.
Each measure was generated in the dataset to assess their feasibility. The diagnostic codes used in each measure were compared with those in the Charlson Comorbidity Index (CCI). Validity was assessed using the prevalence of frailty and relationship with 1-year survival. The Brier score and the c-statistic were used to assess performance and discriminative ability of models with included each measure.
All measures demonstrated feasibility, validity and reliability. Diagnostic codes used in SCARF and CCI have considerable overlap. Prevalence of frailty determined by each differed; SCARF allocating 55.4% of the population to the lowest risk group compared with 85.1% (HFRS) and 81.2% (FS). HFRS and FS demonstrated the greatest difference in 1-year overall survival between those with the lowest and highest measured levels of frailty. Differences in model performance were marginal.
HFRS, SCARF and FS all have value in quantifying frailty in routine administrative health care datasets. The most suitable measure will depend on the context and requirements of each individual epidemiological study.
许多研究表明,结直肠癌的治疗存在与年龄相关的不平等现象。人口老龄化导致的虚弱程度增加可能是造成这种情况的原因之一,但在基于人群的研究中量化虚弱程度具有挑战性。
评估医院虚弱风险评分(HFRS)、二级保健行政记录虚弱(SCARF)指数和虚弱综合征(FS)测量方法在全国结直肠癌队列中的可行性、有效性和可靠性。
使用英国国家卫生服务体系内治疗的 136008 例结直肠癌患者的回顾性基于人群的研究。
在数据集中生成每个测量值,以评估其可行性。在每个测量值中使用的诊断代码与 Charlson 合并症指数(CCI)中的诊断代码进行了比较。有效性通过虚弱的患病率和与 1 年生存率的关系来评估。Brier 评分和 c 统计量用于评估包含每个测量值的模型的性能和区分能力。
所有措施均具有可行性、有效性和可靠性。SCARF 和 CCI 中使用的诊断代码具有很大的重叠。每种方法确定的虚弱患病率不同;SCARF 将 55.4%的人群分配到风险最低的组,而 HFRS 为 85.1%(HFRS)和 81.2%(FS)。HFRS 和 FS 在最低和最高测量水平的虚弱患者之间的 1 年总体生存率方面显示出最大差异。模型性能的差异微不足道。
HFRS、SCARF 和 FS 都可用于在常规行政医疗保健数据集中量化虚弱。最合适的测量方法将取决于每个单独的流行病学研究的背景和要求。